OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
Simon Guiraud, Benjamin Edwards, Arran Babbs, et al.
Human Molecular Genetics (2019) Vol. 28, Iss. 13, pp. 2189-2200
Open Access | Times Cited: 40

Showing 26-50 of 40 citing articles:

Duchenne Muscular Dystrophy Presenting as Incidental Hyper-Transaminasasemia in a Two-Month-Old Male
Uzoego N Chibuzo, Madeline Bruman, Ariela Holguin, et al.
Cureus (2023)
Open Access | Times Cited: 2

Targeting IRES-dependent translation as a novel approach for treating Duchenne muscular dystrophy
Christine Péladeau, Bernard J. Jasmin
RNA Biology (2020) Vol. 18, Iss. 9, pp. 1238-1251
Open Access | Times Cited: 4

Structural Proteins | Dystrophin: A Multifaceted Protein Critical for Muscle Health
D’anna M. Nelson, James M. Ervasti
Elsevier eBooks (2020), pp. 625-638
Closed Access | Times Cited: 3

An overview of recent US-approved gene therapies for Duchenne muscular dystrophy and their respective clinical development programs
Dale K. Yu
Drugs & Therapy Perspectives (2023) Vol. 39, Iss. 4, pp. 156-163
Closed Access | Times Cited: 1

Re-examination of therapeutic management of muscular dystrophies using a vascular smooth muscle-centered approach
Senthilkumar Preethy, Naoki Yamamoto, Shiro Ozasa, et al.
Journal of Smooth Muscle Research (2023) Vol. 59, pp. 67-80
Open Access | Times Cited: 1

Muscular Dystrophy: Mutations in the Dystrophin Gene
Aishwarya Agarwal, Kunal Verma, Shivani Tyagi, et al.
(2024), pp. 341-357
Closed Access

Is duchenne gene therapy a suitable treatment despite its immunogenic class effect?
Annie Tang, Toshifumi Yokota
Expert Opinion on Drug Safety (2024)
Closed Access

Short-Term ONX-0914 Administration: Performance and Muscle Phenotype in Mdx Mice
Dongmin Kwak, Guoxian Wei, LaDora V. Thompson, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 14, pp. 5211-5211
Open Access | Times Cited: 2

Molekularne mechanizmy dystrofii mięśniowej Duchenne’a i nowe możliwości terapeutyczne
Paulina Podkalicka, Małgorzata Myszka, Józef Dulak, et al.
Postępy Biochemii (2022)
Open Access | Times Cited: 1

Effect of Chinese herbal medicines on the overall survival of patients with muscular dystrophies in Taiwan
I‐Ching Chou, Alex C-Y Chang, Chao‐Jung Chen, et al.
Journal of Ethnopharmacology (2021) Vol. 279, pp. 114359-114359
Closed Access | Times Cited: 1

CRISPR-Cas9 mediated endogenous utrophin upregulation improves Duchenne Muscular Dystrophy
Simon Guiraud, Sumitava Dastidar, Fetta Mazed, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Previous Page - Page 2

Scroll to top